| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | NRIP1 DCAF6 ATN1 NACA ZMYND8 NSD1 HIPK2 MED13L PHF8 SRCAP MED15 CCAR1 MAML2 CAMTA1 MED12 NOTCH1 | 4.60e-07 | 562 | 125 | 16 | GO:0003712 |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 9.54e-07 | 4 | 125 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NRIP1 DCAF6 SH3RF1 ATN1 NACA ZMYND8 NSD1 HIPK2 ICE1 MED13L PHF8 SRCAP WNK1 MED15 BAZ2A TIRAP CCAR1 MAML2 CAMTA1 MED12 NOTCH1 | 1.02e-05 | 1160 | 125 | 21 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.13e-05 | 303 | 125 | 10 | GO:0003713 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NRIP1 DCAF6 SH3RF1 ATN1 NACA ZMYND8 NSD1 HIPK2 ICE1 MED13L PHF8 SRCAP WNK1 MED15 BAZ2A TIRAP ITSN2 CCAR1 MAML2 CAMTA1 MED12 NOTCH1 | 3.32e-05 | 1356 | 125 | 22 | GO:0060090 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.64e-04 | 44 | 125 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.84e-04 | 188 | 125 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.53e-04 | 20 | 125 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | transcription factor binding | NRIP1 TEAD2 NACA ZMYND8 SREBF1 NSD1 HIPK2 CRTC1 BAZ2A HEY2 KMT2A TBX20 MED12 RAD23B | 2.66e-04 | 753 | 125 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF704 NRIP1 TEAD2 HIVEP2 ZBTB33 SREBF1 NPAS3 NSD1 POU2F1 STOX1 CIC CREB5 TFE3 ZFHX4 KLF7 CCAR1 HEY2 TBX20 MED12 NPAS2 RAD23B | 2.74e-04 | 1459 | 125 | 21 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF704 NRIP1 TEAD2 HIVEP2 ZBTB33 SREBF1 NSD1 POU2F1 CREB5 TFE3 ZFHX4 KLF7 CCAR1 HEY2 TBX20 MED12 NOTCH1 NPAS2 RAD23B | 3.47e-04 | 1271 | 125 | 19 | GO:0000987 |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 4.98e-04 | 25 | 125 | 3 | GO:0017056 | |
| GeneOntologyMolecularFunction | ATPase inhibitor activity | 5.74e-04 | 6 | 125 | 2 | GO:0042030 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 6.28e-04 | 27 | 125 | 3 | GO:0008139 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF704 NRIP1 TEAD2 HIVEP2 ZBTB33 SREBF1 NSD1 POU2F1 CREB5 TFE3 ZFHX4 KLF7 CCAR1 HEY2 TBX20 MED12 NPAS2 RAD23B | 7.38e-04 | 1244 | 125 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 8.59e-04 | 30 | 125 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 8.75e-04 | 68 | 125 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 9.24e-04 | 69 | 125 | 4 | GO:0016278 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 9.47e-04 | 31 | 125 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 1.03e-03 | 71 | 125 | 4 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.06e-03 | 8 | 125 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NRIP1 ZMYND8 NSD1 HIPK2 CRTC1 BAZ2A HEY2 KMT2A TBX20 MED12 RAD23B | 1.09e-03 | 582 | 125 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.69e-03 | 10 | 125 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 2.90e-03 | 13 | 125 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.22e-03 | 229 | 125 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 3.22e-03 | 229 | 125 | 6 | GO:0003714 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.36e-03 | 231 | 125 | 6 | GO:0005085 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NRIP1 TEAD2 DCAF6 HIVEP2 CDK12 NACA ZMYND8 ASH1L SREBF1 HIPK2 POU2F1 CRTC1 PHF8 CREB5 TFE3 MED15 KANSL3 CSRNP2 KLF7 ASXL3 HEY2 KMT2A MAML2 CAMTA1 MCF2L TBX20 MED12 NOTCH1 NPAS2 | 4.62e-09 | 1390 | 127 | 29 | GO:0045944 |
| GeneOntologyBiologicalProcess | heart trabecula morphogenesis | 3.49e-06 | 38 | 127 | 5 | GO:0061384 | |
| GeneOntologyBiologicalProcess | mesenchymal cell development | 1.25e-05 | 8 | 127 | 3 | GO:0014031 | |
| GeneOntologyBiologicalProcess | trabecula morphogenesis | 2.65e-05 | 57 | 127 | 5 | GO:0061383 | |
| GeneOntologyBiologicalProcess | cardiac atrium morphogenesis | 6.19e-05 | 35 | 127 | 4 | GO:0003209 | |
| GeneOntologyBiologicalProcess | venous blood vessel morphogenesis | 6.23e-05 | 13 | 127 | 3 | GO:0048845 | |
| GeneOntologyBiologicalProcess | cardiac atrium development | 1.28e-04 | 42 | 127 | 4 | GO:0003230 | |
| GeneOntologyBiologicalProcess | heart valve formation | 1.46e-04 | 17 | 127 | 3 | GO:0003188 | |
| GeneOntologyBiologicalProcess | ventricular trabecula myocardium morphogenesis | 1.46e-04 | 17 | 127 | 3 | GO:0003222 | |
| GeneOntologyCellularComponent | Golgi lumen | MUC3B MUC16 MUC5B MUC12 MUC17 MUC2 MUC3A MUC4 MUC5AC MUC6 MUC7 | 6.22e-11 | 109 | 127 | 11 | GO:0005796 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NRIP1 TEAD2 SETD1B CDK12 NSD1 HIPK2 POM121L2 POU2F1 ICE1 MED13L SRCAP POM121C MED15 BAZ2A UBAP2L ASXL3 KMT2A CDC27 POM121B MED12 AQR NPAS2 RAD23B | 8.42e-06 | 1377 | 127 | 23 | GO:0140513 |
| GeneOntologyCellularComponent | chromatin | NRIP1 TEAD2 ZBTB33 ZMYND8 SREBF1 NPAS3 NSD1 POU2F1 ICE1 SRCAP CIC CREB5 TFE3 KANSL3 CSRNP2 ZFHX4 KLF7 BAZ2A HEY2 TBX20 STAG3 NPAS2 | 7.95e-05 | 1480 | 127 | 22 | GO:0000785 |
| GeneOntologyCellularComponent | mucus layer | 1.09e-04 | 3 | 127 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 3.01e-04 | 96 | 127 | 5 | GO:0010494 | |
| GeneOntologyCellularComponent | external encapsulating structure | CD248 CCDC80 MUC5B PKHD1L1 MEGF9 MUC17 SERPING1 MUC2 MUC4 MUC5AC MUC6 OTOG | 6.81e-04 | 658 | 127 | 12 | GO:0030312 |
| HumanPheno | Diagnostic behavioral phenotype | HIVEP2 SETD1B ASH1L NSD1 ADGRL1 TSC1 CNKSR2 QRICH1 MED13L SRCAP CIC TFE3 UBAP2L ZDHHC9 ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 2.85e-06 | 747 | 43 | 19 | HP:0025783 |
| HumanPheno | Autistic behavior | HIVEP2 SETD1B ASH1L NSD1 ADGRL1 TSC1 CNKSR2 QRICH1 MED13L SRCAP CIC TFE3 UBAP2L ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 3.24e-06 | 678 | 43 | 18 | HP:0000729 |
| HumanPheno | Heart murmur | 1.57e-05 | 39 | 43 | 5 | HP:0030148 | |
| HumanPheno | Abnormal heart sound | 2.28e-05 | 42 | 43 | 5 | HP:0031657 | |
| HumanPheno | Hyperactivity | HIVEP2 ASH1L NSD1 ADGRL1 TSC1 CNKSR2 MED13L SRCAP CIC UBAP2L ZDHHC9 KMT2A DEPDC5 CAMTA1 MED12 | 2.64e-05 | 558 | 43 | 15 | HP:0000752 |
| HumanPheno | Long fingers | HIVEP2 SETD1B PHF8 WNK1 CIC TFE3 ZDHHC9 ASXL3 HEY2 KMT2A MED12 | 3.12e-05 | 306 | 43 | 11 | HP:0100807 |
| HumanPheno | Restricted or repetitive behaviors or interests | ASH1L ADGRL1 TSC1 SRCAP CIC TFE3 UBAP2L ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 3.33e-05 | 368 | 43 | 12 | HP:0031432 |
| HumanPheno | Bulbous nose | 3.40e-05 | 201 | 43 | 9 | HP:0000414 | |
| HumanPheno | Perseverative thought | ASH1L ADGRL1 TSC1 SRCAP CIC TFE3 UBAP2L ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 4.23e-05 | 377 | 43 | 12 | HP:0030223 |
| HumanPheno | Disordered formal thought process | ASH1L ADGRL1 TSC1 SRCAP CIC TFE3 UBAP2L ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 5.35e-05 | 386 | 43 | 12 | HP:0025769 |
| HumanPheno | Abnormal nasal tip morphology | ATN1 NSD1 QRICH1 MED13L PHF8 SRCAP TFE3 UBAP2L ASXL3 KMT2A CAMTA1 MED12 | 5.35e-05 | 386 | 43 | 12 | HP:0000436 |
| HumanPheno | Motor stereotypy | 8.15e-05 | 280 | 43 | 10 | HP:0000733 | |
| HumanPheno | Abnormal thought pattern | ASH1L ADGRL1 TSC1 SRCAP CIC TFE3 UBAP2L ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 8.36e-05 | 404 | 43 | 12 | HP:5200269 |
| HumanPheno | Abnormal lower lip morphology | 1.45e-04 | 242 | 43 | 9 | HP:0000178 | |
| HumanPheno | Disinhibition | HIVEP2 ASH1L NSD1 ADGRL1 TSC1 CNKSR2 MED13L SRCAP CIC TFE3 UBAP2L ZDHHC9 ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 1.50e-04 | 807 | 43 | 17 | HP:0000734 |
| HumanPheno | Inappropriate behavior | HIVEP2 ASH1L NSD1 ADGRL1 TSC1 CNKSR2 MED13L SRCAP CIC TFE3 UBAP2L ZDHHC9 ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 1.50e-04 | 807 | 43 | 17 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | HIVEP2 ASH1L NSD1 ADGRL1 TSC1 CNKSR2 MED13L SRCAP CIC TFE3 UBAP2L ZDHHC9 ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 1.50e-04 | 807 | 43 | 17 | HP:5200123 |
| HumanPheno | Social disinhibition | HIVEP2 ASH1L NSD1 ADGRL1 TSC1 CNKSR2 MED13L SRCAP CIC TFE3 UBAP2L ZDHHC9 ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 1.50e-04 | 807 | 43 | 17 | HP:5200029 |
| HumanPheno | Frontal upsweep of hair | 1.51e-04 | 33 | 43 | 4 | HP:0002236 | |
| HumanPheno | Pes planus | HIVEP2 NSD1 PHF8 CIC TFE3 UBAP2L ZDHHC9 ASXL3 HEY2 KMT2A MED12 | 1.56e-04 | 365 | 43 | 11 | HP:0001763 |
| HumanPheno | Aggressive behavior | HIVEP2 NSD1 TSC1 CNKSR2 MED13L SRCAP TFE3 UBAP2L ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 2.13e-04 | 516 | 43 | 13 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | HIVEP2 NSD1 TSC1 CNKSR2 MED13L SRCAP TFE3 UBAP2L ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 2.13e-04 | 516 | 43 | 13 | HP:0006919 |
| HumanPheno | Short attention span | NSD1 ADGRL1 TSC1 CNKSR2 SRCAP CIC TFE3 UBAP2L ZDHHC9 KMT2A DEPDC5 CAMTA1 MED12 | 2.17e-04 | 517 | 43 | 13 | HP:0000736 |
| HumanPheno | Reduced attention regulation | NSD1 ADGRL1 TSC1 CNKSR2 SRCAP CIC TFE3 UBAP2L ZDHHC9 KMT2A DEPDC5 CAMTA1 MED12 | 2.58e-04 | 526 | 43 | 13 | HP:5200044 |
| HumanPheno | Congenital abnormal hair pattern | 2.95e-04 | 327 | 43 | 10 | HP:0011361 | |
| HumanPheno | Delayed speech and language development | HIVEP2 SETD1B ATN1 ASH1L NSD1 ADGRL1 CNKSR2 QRICH1 MED13L PHF8 SRCAP CIC TFE3 UBAP2L ASXL3 KMT2A CAMTA1 RUBCN MED12 OTOG | 3.08e-04 | 1123 | 43 | 20 | HP:0000750 |
| HumanPheno | Abnormally increased volition | HIVEP2 ASH1L NSD1 ADGRL1 TSC1 CNKSR2 MED13L SRCAP CIC TFE3 UBAP2L ZDHHC9 ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 3.76e-04 | 869 | 43 | 17 | HP:5200263 |
| HumanPheno | Abnormal hair whorl | 3.90e-04 | 42 | 43 | 4 | HP:0010721 | |
| HumanPheno | Long toe | 4.43e-04 | 168 | 43 | 7 | HP:0010511 | |
| HumanPheno | Attention deficit hyperactivity disorder | NSD1 ADGRL1 TSC1 CNKSR2 SRCAP CIC UBAP2L ZDHHC9 DEPDC5 CAMTA1 MED12 | 4.63e-04 | 413 | 43 | 11 | HP:0007018 |
| HumanPheno | Hypermetropia | 5.34e-04 | 288 | 43 | 9 | HP:0000540 | |
| HumanPheno | Open mouth | 5.37e-04 | 124 | 43 | 6 | HP:0000194 | |
| HumanPheno | Language impairment | HIVEP2 SETD1B ATN1 ASH1L NSD1 ADGRL1 CNKSR2 QRICH1 MED13L PHF8 SRCAP CIC TFE3 UBAP2L ASXL3 KMT2A CAMTA1 RUBCN MED12 OTOG | 6.02e-04 | 1178 | 43 | 20 | HP:0002463 |
| HumanPheno | Abnormality of the hairline | 6.21e-04 | 294 | 43 | 9 | HP:0009553 | |
| HumanPheno | Abnormal social development | HIVEP2 ASH1L NSD1 ADGRL1 TSC1 CNKSR2 MED13L SRCAP CIC TFE3 UBAP2L ZDHHC9 ASXL3 KMT2A DEPDC5 CAMTA1 MED12 | 6.41e-04 | 908 | 43 | 17 | HP:0025732 |
| HumanPheno | Focal cortical dysplasia type II | 6.85e-04 | 5 | 43 | 2 | HP:0032051 | |
| Domain | VWF_type-D | 5.21e-10 | 16 | 122 | 6 | IPR001846 | |
| Domain | VWFD | 5.21e-10 | 16 | 122 | 6 | PS51233 | |
| Domain | VWD | 5.21e-10 | 16 | 122 | 6 | SM00216 | |
| Domain | VWD | 5.21e-10 | 16 | 122 | 6 | PF00094 | |
| Domain | C8 | 8.36e-09 | 12 | 122 | 5 | PF08742 | |
| Domain | TIL | 8.36e-09 | 12 | 122 | 5 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 1.35e-08 | 13 | 122 | 5 | IPR014853 | |
| Domain | C8 | 1.35e-08 | 13 | 122 | 5 | SM00832 | |
| Domain | TIL_dom | 2.09e-08 | 14 | 122 | 5 | IPR002919 | |
| Domain | VWC_out | 1.18e-07 | 19 | 122 | 5 | SM00215 | |
| Domain | CT | 2.64e-07 | 22 | 122 | 5 | SM00041 | |
| Domain | SEA | 3.35e-07 | 23 | 122 | 5 | PS50024 | |
| Domain | SEA_dom | 3.35e-07 | 23 | 122 | 5 | IPR000082 | |
| Domain | Cys_knot_C | 5.24e-07 | 25 | 122 | 5 | IPR006207 | |
| Domain | CTCK_2 | 5.24e-07 | 25 | 122 | 5 | PS01225 | |
| Domain | SEA | 1.65e-06 | 14 | 122 | 4 | SM00200 | |
| Domain | ZF_PHD_2 | 2.93e-06 | 95 | 122 | 7 | PS50016 | |
| Domain | Post-SET_dom | 2.97e-06 | 16 | 122 | 4 | IPR003616 | |
| Domain | PostSET | 2.97e-06 | 16 | 122 | 4 | SM00508 | |
| Domain | POST_SET | 2.97e-06 | 16 | 122 | 4 | PS50868 | |
| Domain | ZF_PHD_1 | 3.14e-06 | 96 | 122 | 7 | PS01359 | |
| Domain | WxxW_domain | 5.36e-06 | 6 | 122 | 3 | IPR025155 | |
| Domain | Mucin2_WxxW | 5.36e-06 | 6 | 122 | 3 | PF13330 | |
| Domain | EGF-like_dom | 5.52e-06 | 249 | 122 | 10 | IPR000742 | |
| Domain | EGF_1 | 6.81e-06 | 255 | 122 | 10 | PS00022 | |
| Domain | VWF_dom | 7.68e-06 | 42 | 122 | 5 | IPR001007 | |
| Domain | EGF-like_CS | 8.35e-06 | 261 | 122 | 10 | IPR013032 | |
| Domain | EGF_2 | 9.54e-06 | 265 | 122 | 10 | PS01186 | |
| Domain | PHD | 9.57e-06 | 75 | 122 | 6 | PF00628 | |
| Domain | SEA | 1.16e-05 | 22 | 122 | 4 | PF01390 | |
| Domain | Znf_PHD-finger | 1.29e-05 | 79 | 122 | 6 | IPR019787 | |
| Domain | EGF | 2.41e-05 | 235 | 122 | 9 | SM00181 | |
| Domain | EGF_3 | 2.41e-05 | 235 | 122 | 9 | PS50026 | |
| Domain | PHD | 2.56e-05 | 89 | 122 | 6 | SM00249 | |
| Domain | AT_hook | 2.71e-05 | 27 | 122 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 2.71e-05 | 27 | 122 | 4 | IPR017956 | |
| Domain | Znf_PHD | 2.91e-05 | 91 | 122 | 6 | IPR001965 | |
| Domain | SET | 1.46e-04 | 41 | 122 | 4 | PF00856 | |
| Domain | BROMODOMAIN_2 | 1.46e-04 | 41 | 122 | 4 | PS50014 | |
| Domain | Bromodomain | 1.60e-04 | 42 | 122 | 4 | IPR001487 | |
| Domain | BROMO | 1.60e-04 | 42 | 122 | 4 | SM00297 | |
| Domain | - | 1.60e-04 | 42 | 122 | 4 | 1.20.920.10 | |
| Domain | CTCK_1 | 2.07e-04 | 18 | 122 | 3 | PS01185 | |
| Domain | SET | 2.29e-04 | 46 | 122 | 4 | SM00317 | |
| Domain | - | DAB1 CNKSR2 PLEKHG2 PLEKHA6 ARHGEF11 RASAL3 ITSN2 MCF2L TNS1 PLCE1 | 2.48e-04 | 391 | 122 | 10 | 2.30.29.30 |
| Domain | UBA | 2.49e-04 | 47 | 122 | 4 | PS50030 | |
| Domain | SUZ | 2.52e-04 | 4 | 122 | 2 | IPR024771 | |
| Domain | SUZ | 2.52e-04 | 4 | 122 | 2 | PS51673 | |
| Domain | SET_dom | 3.16e-04 | 50 | 122 | 4 | IPR001214 | |
| Domain | SET | 3.16e-04 | 50 | 122 | 4 | PS50280 | |
| Domain | Znf_FYVE_PHD | 4.10e-04 | 147 | 122 | 6 | IPR011011 | |
| Domain | AWS | 4.18e-04 | 5 | 122 | 2 | SM00570 | |
| Domain | AWS | 4.18e-04 | 5 | 122 | 2 | PS51215 | |
| Domain | AWS_dom | 4.18e-04 | 5 | 122 | 2 | IPR006560 | |
| Domain | PAS_fold_3 | 4.38e-04 | 23 | 122 | 3 | IPR013655 | |
| Domain | PAS_3 | 4.38e-04 | 23 | 122 | 3 | PF08447 | |
| Domain | PH_dom-like | DAB1 CNKSR2 PLEKHG2 PLEKHA6 ARHGEF11 RASAL3 ITSN2 MCF2L TNS1 PLCE1 | 4.87e-04 | 426 | 122 | 10 | IPR011993 |
| Domain | PAS-assoc_C | 4.98e-04 | 24 | 122 | 3 | IPR000700 | |
| Domain | PAC | 6.33e-04 | 26 | 122 | 3 | IPR001610 | |
| Domain | PAC | 6.33e-04 | 26 | 122 | 3 | PS50113 | |
| Domain | PAC | 6.33e-04 | 26 | 122 | 3 | SM00086 | |
| Domain | - | RC3H2 SH3RF1 MARCHF8 ZMYND8 ASH1L NSD1 PHF8 BAZ2A KMT2A SH3RF3 | 7.31e-04 | 449 | 122 | 10 | 3.30.40.10 |
| Domain | - | 7.45e-04 | 109 | 122 | 5 | 4.10.280.10 | |
| Domain | HLH | 8.08e-04 | 111 | 122 | 5 | PF00010 | |
| Domain | Zinc_finger_PHD-type_CS | 8.63e-04 | 65 | 122 | 4 | IPR019786 | |
| Domain | Znf_RING/FYVE/PHD | RC3H2 SH3RF1 MARCHF8 ZMYND8 ASH1L NSD1 PHF8 BAZ2A KMT2A SH3RF3 | 8.65e-04 | 459 | 122 | 10 | IPR013083 |
| Domain | HLH | 9.86e-04 | 116 | 122 | 5 | SM00353 | |
| Domain | RhoGEF | 1.02e-03 | 68 | 122 | 4 | SM00325 | |
| Domain | BHLH | 1.02e-03 | 117 | 122 | 5 | PS50888 | |
| Domain | bHLH_dom | 1.06e-03 | 118 | 122 | 5 | IPR011598 | |
| Domain | RhoGEF | 1.14e-03 | 70 | 122 | 4 | PF00621 | |
| Domain | DH_2 | 1.14e-03 | 70 | 122 | 4 | PS50010 | |
| Domain | PAS | 1.17e-03 | 32 | 122 | 3 | SM00091 | |
| Domain | - | 1.20e-03 | 71 | 122 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 1.20e-03 | 71 | 122 | 4 | IPR000219 | |
| Domain | PAS | 1.40e-03 | 34 | 122 | 3 | PS50112 | |
| Domain | PAS | 1.40e-03 | 34 | 122 | 3 | IPR000014 | |
| Domain | EGF | 1.43e-03 | 126 | 122 | 5 | PF00008 | |
| Domain | VWFC_1 | 1.66e-03 | 36 | 122 | 3 | PS01208 | |
| Domain | SH3_9 | 1.70e-03 | 78 | 122 | 4 | PF14604 | |
| Domain | Bromodomain | 1.94e-03 | 38 | 122 | 3 | PF00439 | |
| Domain | VWFC_2 | 1.94e-03 | 38 | 122 | 3 | PS50184 | |
| Domain | VWC | 1.94e-03 | 38 | 122 | 3 | SM00214 | |
| Domain | PH | 2.35e-03 | 278 | 122 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 2.40e-03 | 279 | 122 | 7 | PS50003 | |
| Domain | EGF_CA | 2.44e-03 | 86 | 122 | 4 | PF07645 | |
| Domain | PH_domain | 2.44e-03 | 280 | 122 | 7 | IPR001849 | |
| Domain | UBA | 2.96e-03 | 44 | 122 | 3 | IPR015940 | |
| Domain | EGF_Ca-bd_CS | 3.76e-03 | 97 | 122 | 4 | IPR018097 | |
| Domain | EGF_CA | 4.05e-03 | 99 | 122 | 4 | PS01187 | |
| Domain | - | 4.20e-03 | 15 | 122 | 2 | 3.30.70.960 | |
| Domain | Glyco_hormone_CN | 4.20e-03 | 15 | 122 | 2 | IPR006208 | |
| Domain | Cys_knot | 4.20e-03 | 15 | 122 | 2 | PF00007 | |
| Domain | AT_hook | 4.78e-03 | 16 | 122 | 2 | PF02178 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.16e-03 | 106 | 122 | 4 | IPR000152 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.14e-16 | 16 | 95 | 9 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 4.52e-16 | 17 | 95 | 9 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.47e-14 | 23 | 95 | 9 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 5.53e-14 | 26 | 95 | 9 | M27483 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.51e-11 | 68 | 95 | 10 | M27303 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 5.43e-11 | 21 | 95 | 7 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.95e-10 | 62 | 95 | 9 | M546 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.08e-08 | 143 | 95 | 10 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.60e-08 | 111 | 95 | 9 | M27416 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.46e-07 | 60 | 95 | 7 | MM15636 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 4.14e-07 | 140 | 95 | 9 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 6.93e-06 | 250 | 95 | 10 | M27554 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 8.60e-06 | 109 | 95 | 7 | MM15164 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 2.54e-04 | 46 | 95 | 4 | MM14933 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.11e-04 | 20 | 95 | 3 | M27881 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 6.12e-04 | 25 | 95 | 3 | M27880 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 9.23e-04 | 7 | 95 | 2 | MM1566 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 9.23e-04 | 7 | 95 | 2 | M22049 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 9.57e-04 | 65 | 95 | 4 | M39374 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.17e-03 | 175 | 95 | 6 | MM14941 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.20e-03 | 118 | 95 | 5 | M27316 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 1.26e-03 | 70 | 95 | 4 | M27231 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.26e-03 | 70 | 95 | 4 | M938 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.36e-20 | 18 | 128 | 10 | 18834073 | |
| Pubmed | FNIP2 SETD1B ADGRL1 R3HDM2 TSC1 CNKSR2 MED13L PHF8 MEGF9 BAZ2A UBAP2L PRRC2C ITSN2 RIPOR1 CAMTA1 MCF2L RUBCN AQR PLCE1 | 8.93e-16 | 407 | 128 | 19 | 12693553 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TEAD2 HIVEP2 SETD1B SH3RF1 CDK12 SREBF1 NSD1 ADGRL1 ICE1 MED13L SRCAP ARHGEF11 POM121C WNK1 CIC TFE3 MICALL1 KANSL3 HEG1 MAP1S RIPOR1 DEPDC5 MCF2L MED12 NOTCH1 | 3.02e-13 | 1105 | 128 | 25 | 35748872 |
| Pubmed | 3.73e-12 | 6 | 128 | 5 | 19110483 | ||
| Pubmed | 1.75e-10 | 4 | 128 | 4 | 23807779 | ||
| Pubmed | 1.75e-10 | 4 | 128 | 4 | 17471237 | ||
| Pubmed | 1.75e-10 | 4 | 128 | 4 | 14984930 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 1.75e-10 | 4 | 128 | 4 | 29869461 | |
| Pubmed | 1.75e-10 | 4 | 128 | 4 | 12676567 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 8.73e-10 | 5 | 128 | 4 | 11062147 | |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 8.73e-10 | 5 | 128 | 4 | 16475027 | |
| Pubmed | TEAD2 ZBTB33 ATN1 NACA ZMYND8 MRPL43 HIPK2 POU2F1 R3HDM2 PROSER1 PHF8 SRCAP POM121C CIC TFE3 MED15 KANSL3 LARP4B ZFHX4 UBAP2L PRRC2C CCAR1 KMT2A | 2.41e-09 | 1429 | 128 | 23 | 35140242 | |
| Pubmed | HIVEP2 SH3RF1 HIPK2 ADGRL1 CRTC1 MUC12 PLEKHA6 ARHGEF11 POM121C WNK1 CIC RASAL3 ITSN2 TNS1 | 3.66e-09 | 486 | 128 | 14 | 20936779 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ATN1 ZMYND8 MRPL43 CNKSR2 POM121C WNK1 CIC LARP4B RASAL3 MAP1S MAML2 CAMTA1 NOTCH1 | 7.71e-09 | 430 | 128 | 13 | 35044719 |
| Pubmed | ZNF704 TEAD2 ZBTB33 ZMYND8 ASH1L SREBF1 POU2F1 PHF8 SRCAP PKHD1L1 CIC TFE3 KLF7 BAZ2A CCAR1 TBX20 NPAS2 | 7.87e-09 | 808 | 128 | 17 | 20412781 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATN1 CDK12 ZMYND8 USP24 POU2F1 PHF8 CIC MICALL1 KANSL3 PTPRC MAP1S BAZ2A UBAP2L CCAR1 KMT2A RIPOR1 | 2.86e-08 | 774 | 128 | 16 | 15302935 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | RC3H2 TEAD2 HIVEP2 ZBTB33 ASH1L SREBF1 NPAS3 POU2F1 CIC CREB5 TFE3 ZFHX4 HEY2 KMT2A CAMTA1 TBX20 NPAS2 | 4.29e-08 | 908 | 128 | 17 | 19274049 |
| Pubmed | Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression. | 4.87e-08 | 3 | 128 | 3 | 23305535 | |
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 4.87e-08 | 3 | 128 | 3 | 18163520 | |
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 18825309 | ||
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 10512748 | ||
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 18300795 | ||
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 19718741 | ||
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 20065027 | ||
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 23464473 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF704 NRIP1 ZFAND3 DCAF6 HIVEP2 DEPTOR ASH1L DAB1 HIPK2 ADGRL1 ADGRG6 LRP8 KANSL3 KLF7 UBAP2L CCAR1 RIPOR1 CAMTA1 MCF2L SH3RF3 NPAS2 | 1.23e-07 | 1489 | 128 | 21 | 28611215 |
| Pubmed | 1.94e-07 | 4 | 128 | 3 | 25638393 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 1.94e-07 | 4 | 128 | 3 | 22269464 | |
| Pubmed | 1.94e-07 | 4 | 128 | 3 | 21647207 | ||
| Pubmed | 1.94e-07 | 4 | 128 | 3 | 33154304 | ||
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 1.94e-07 | 4 | 128 | 3 | 24901817 | |
| Pubmed | 1.94e-07 | 4 | 128 | 3 | 36367122 | ||
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 1.94e-07 | 4 | 128 | 3 | 20929551 | |
| Pubmed | 1.94e-07 | 4 | 128 | 3 | 21596555 | ||
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 1.94e-07 | 4 | 128 | 3 | 27298226 | |
| Pubmed | Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. | 1.94e-07 | 4 | 128 | 3 | 18198997 | |
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 1.94e-07 | 4 | 128 | 3 | 17401217 | |
| Pubmed | 1.94e-07 | 4 | 128 | 3 | 25298197 | ||
| Pubmed | TEAD2 HIVEP2 ZBTB33 SH3RF1 ZMYND8 SREBF1 NPAS3 POU2F1 QRICH1 CIC TFE3 KLF7 BAZ2A KMT2A | 3.86e-07 | 709 | 128 | 14 | 22988430 | |
| Pubmed | 4.21e-07 | 41 | 128 | 5 | 22675208 | ||
| Pubmed | NRIP1 ATN1 ZMYND8 SREBF1 R3HDM2 QRICH1 WNK1 CIC PCDH17 MED15 UBAP2L NOTCH1 RAD23B | 4.24e-07 | 608 | 128 | 13 | 16713569 | |
| Pubmed | 4.84e-07 | 5 | 128 | 3 | 12507512 | ||
| Pubmed | 4.84e-07 | 5 | 128 | 3 | 12135769 | ||
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 4.84e-07 | 5 | 128 | 3 | 16188033 | |
| Pubmed | 4.84e-07 | 5 | 128 | 3 | 24840470 | ||
| Pubmed | 4.84e-07 | 5 | 128 | 3 | 18035521 | ||
| Pubmed | 4.84e-07 | 5 | 128 | 3 | 22261707 | ||
| Pubmed | An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. | 6.50e-07 | 19 | 128 | 4 | 16799563 | |
| Pubmed | 7.18e-07 | 268 | 128 | 9 | 33640491 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | HIVEP2 ATN1 POU2F1 PROSER1 POM121C MED15 ZFHX4 ASXL3 KMT2A MED12 | 7.63e-07 | 351 | 128 | 10 | 38297188 |
| Pubmed | ZBTB33 CDK12 USP24 NSD1 PHF8 SRCAP MED15 BAZ2A UBAP2L PRRC2C KMT2A MED12 | 9.59e-07 | 549 | 128 | 12 | 38280479 | |
| Pubmed | Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex. | 9.66e-07 | 6 | 128 | 3 | 18957219 | |
| Pubmed | 9.66e-07 | 6 | 128 | 3 | 17982272 | ||
| Pubmed | 1.69e-06 | 7 | 128 | 3 | 19945174 | ||
| Pubmed | 2.49e-06 | 104 | 128 | 6 | 9205841 | ||
| Pubmed | ZFAND3 ASH1L AKNAD1 NSD1 HIPK2 CRTC1 SRCAP WNK1 LARP4B PTPRC UBAP2L MAP3K9 CAMTA1 CDC27 TNS1 SZRD1 | 2.53e-06 | 1084 | 128 | 16 | 11544199 | |
| Pubmed | Germinal Center Selection and Affinity Maturation Require Dynamic Regulation of mTORC1 Kinase. | 2.69e-06 | 8 | 128 | 3 | 28636954 | |
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 2.69e-06 | 8 | 128 | 3 | 23130995 | |
| Pubmed | 4.21e-06 | 425 | 128 | 10 | 24999758 | ||
| Pubmed | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. | 5.73e-06 | 10 | 128 | 3 | 23746844 | |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 5.81e-06 | 69 | 128 | 5 | 28481362 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ATN1 CDK12 MUC16 R3HDM2 PLEKHA6 POM121C CIC ASXL3 MUC2 MUC3A TNS1 | 6.66e-06 | 552 | 128 | 11 | 10737800 |
| Pubmed | DNA Damage Regulates Translation through β-TRCP Targeting of CReP. | 8.39e-06 | 35 | 128 | 4 | 26091241 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZBTB33 CDK12 NACA ZMYND8 TSC1 ICE1 SRCAP POM121C WNK1 CIC BAZ2A UBAP2L PRRC2C KMT2A | 9.42e-06 | 934 | 128 | 14 | 33916271 |
| Pubmed | CDK12 NACA ZMYND8 NSD1 CRTC1 ICE1 ARHGEF11 CIC MED15 LARP4B BAZ2A ITSN2 CCAR1 KMT2A CDC27 MED12 AQR RAD23B | 9.84e-06 | 1497 | 128 | 18 | 31527615 | |
| Pubmed | 1.02e-05 | 281 | 128 | 8 | 24163370 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 7513696 | ||
| Pubmed | Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma. | 1.34e-05 | 2 | 128 | 2 | 19269006 | |
| Pubmed | Concurrent activation of growth factor and nutrient arms of mTORC1 induces oxidative liver injury. | 1.34e-05 | 2 | 128 | 2 | 31754457 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 38093390 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 37146737 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 28343305 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 1.34e-05 | 2 | 128 | 2 | 14988081 | |
| Pubmed | Tumor Suppressor HIPK2 Regulates Malignant Growth via Phosphorylation of Notch1. | 1.34e-05 | 2 | 128 | 2 | 27335110 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15563276 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17621824 | ||
| Pubmed | MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. | 1.34e-05 | 2 | 128 | 2 | 18475301 | |
| Pubmed | Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts. | 1.34e-05 | 2 | 128 | 2 | 20946627 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22220206 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 12459324 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 24317696 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22391959 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 1.34e-05 | 2 | 128 | 2 | 35776514 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 24327612 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19052232 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 28321513 | ||
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 1.34e-05 | 2 | 128 | 2 | 28607090 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 24108462 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 34861462 | ||
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 1.34e-05 | 2 | 128 | 2 | 10973822 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 30504806 | ||
| Pubmed | Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens. | 1.34e-05 | 2 | 128 | 2 | 36675234 | |
| Pubmed | MUC7 Level As A New Saliva Risk Factor For Dental Caries In Adult Patients. | 1.34e-05 | 2 | 128 | 2 | 30745804 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17321686 | ||
| Pubmed | Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas. | 1.34e-05 | 2 | 128 | 2 | 17334997 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 31030254 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 26796488 | ||
| Pubmed | Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma. | 1.34e-05 | 2 | 128 | 2 | 20731025 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15729701 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 20625861 | ||
| Interaction | TOP3B interactions | RC3H2 TEAD2 HIVEP2 SETD1B SH3RF1 CDK12 SREBF1 NSD1 ADGRL1 R3HDM2 ICE1 MED13L SRCAP ARHGEF11 POM121C WNK1 CIC TFE3 MICALL1 KANSL3 LARP4B HEG1 MAP1S UBAP2L RIPOR1 DEPDC5 MCF2L MED12 NOTCH1 | 1.51e-08 | 1470 | 124 | 29 | int:TOP3B |
| Interaction | HCFC1 interactions | SETD1B ATN1 POU2F1 PHF8 CIC MED15 KANSL3 UBAP2L PRRC2C ASXL3 KMT2A NOTCH1 | 2.66e-07 | 293 | 124 | 12 | int:HCFC1 |
| Interaction | AR interactions | NRIP1 DCAF6 ZBTB33 ATN1 ZMYND8 SREBF1 NSD1 HIPK2 POU2F1 MED13L SRCAP CIC MED15 KANSL3 UBAP2L CCAR1 KMT2A CDC27 TNS1 MED12 | 2.67e-06 | 992 | 124 | 20 | int:AR |
| Interaction | NUP43 interactions | SETD1B ATN1 CDK12 ZMYND8 ASH1L NSD1 ICE1 PHF8 SRCAP POM121C KANSL3 BAZ2A PRRC2C KMT2A MED12 | 7.02e-06 | 625 | 124 | 15 | int:NUP43 |
| Interaction | MED15 interactions | 1.67e-05 | 131 | 124 | 7 | int:MED15 | |
| Interaction | TLE3 interactions | HIVEP2 ATN1 CDK12 PROSER1 QRICH1 CIC MED15 CCAR1 KMT2A TBX20 NOTCH1 | 2.12e-05 | 376 | 124 | 11 | int:TLE3 |
| Interaction | YWHAG interactions | RC3H2 HIVEP2 ZBTB33 SH3RF1 CDK12 USP24 CRTC1 R3HDM2 TSC1 PLEKHG2 WNK1 CIC TFE3 MICALL1 PRRC2C MAP3K9 KMT2A SH3RF3 RUBCN AQR OTOG | 2.33e-05 | 1248 | 124 | 21 | int:YWHAG |
| Interaction | SIAH2 interactions | 4.46e-05 | 104 | 124 | 6 | int:SIAH2 | |
| Interaction | NLK interactions | 7.15e-05 | 70 | 124 | 5 | int:NLK | |
| Interaction | KANSL2 interactions | 7.15e-05 | 70 | 124 | 5 | int:KANSL2 | |
| Interaction | SIAH1 interactions | 7.26e-05 | 223 | 124 | 8 | int:SIAH1 | |
| Interaction | NR2E1 interactions | 8.57e-05 | 38 | 124 | 4 | int:NR2E1 | |
| Interaction | PHF20L1 interactions | 9.95e-05 | 75 | 124 | 5 | int:PHF20L1 | |
| Interaction | KAT2A interactions | 1.26e-04 | 180 | 124 | 7 | int:KAT2A | |
| Interaction | YWHAH interactions | NRIP1 HIVEP2 SH3RF1 CRTC1 R3HDM2 TSC1 PLEKHG2 WNK1 CIC TFE3 MICALL1 PRRC2C MAP3K9 KMT2A SH3RF3 RUBCN AQR OTOG | 1.39e-04 | 1102 | 124 | 18 | int:YWHAH |
| Interaction | ALG13 interactions | 1.40e-04 | 183 | 124 | 7 | int:ALG13 | |
| Interaction | ATN1 interactions | 1.60e-04 | 187 | 124 | 7 | int:ATN1 | |
| Interaction | ITGB2 interactions | 1.67e-04 | 132 | 124 | 6 | int:ITGB2 | |
| Interaction | MYB interactions | 1.74e-04 | 133 | 124 | 6 | int:MYB | |
| Interaction | CRX interactions | 1.78e-04 | 254 | 124 | 8 | int:CRX | |
| Interaction | RBPJ interactions | 1.78e-04 | 254 | 124 | 8 | int:RBPJ | |
| Interaction | ZP3 interactions | 2.05e-04 | 19 | 124 | 3 | int:ZP3 | |
| Cytoband | 7q22 | 1.66e-04 | 38 | 128 | 3 | 7q22 | |
| Cytoband | 11p15.5 | 3.46e-04 | 118 | 128 | 4 | 11p15.5 | |
| GeneFamily | CD molecules|Mucins | MUC3B MUC16 MUC5B MUC12 MUC17 MUC2 MUC3A MUC4 MUC5AC MUC6 MUC7 | 3.26e-21 | 21 | 83 | 11 | 648 |
| GeneFamily | PHD finger proteins | 3.57e-06 | 90 | 83 | 6 | 88 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.72e-05 | 34 | 83 | 4 | 487 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.51e-04 | 110 | 83 | 5 | 420 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.40e-04 | 66 | 83 | 4 | 722 | |
| GeneFamily | Cyclins|Mediator complex | 4.61e-04 | 33 | 83 | 3 | 1061 | |
| GeneFamily | PWWP domain containing | 4.53e-03 | 22 | 83 | 2 | 1147 | |
| Coexpression | NABA_ECM_AFFILIATED | MUC16 MUC5B MUC12 OPRPN MUC17 MUC2 MUC3A MUC4 MUC5AC MUC6 MUC7 | 6.58e-10 | 170 | 126 | 11 | M5880 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NRIP1 HIVEP2 ZMYND8 USP24 R3HDM2 MED13L PHF8 CREB5 ADGRG6 LARP4B HEG1 KLF7 PRRC2C ITSN2 OSMR CDC27 AQR PLCE1 RAD23B | 2.84e-08 | 856 | 126 | 19 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NRIP1 HIVEP2 ZMYND8 USP24 R3HDM2 MED13L ADGRG6 LARP4B HEG1 KLF7 PRRC2C ITSN2 CDC27 RAD23B | 5.83e-08 | 466 | 126 | 14 | M13522 |
| Coexpression | GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP | 4.52e-07 | 195 | 126 | 9 | M3118 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.99e-06 | 300 | 126 | 10 | M8702 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP | ZNF704 DEPTOR PRR36 NACA ASH1L LARP4B CSRNP2 MEGF9 BAZ2A PRRC2C RUBCN | 2.68e-06 | 385 | 126 | 11 | M2840 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ZMYND8 NPAS3 ADGRL1 POU2F1 FHOD3 PLEKHA6 MED13L NCR3LG1 PCDH17 ZFHX4 KLF7 MEGF9 ASXL3 SLITRK5 MAP3K9 CAMTA1 MCF2L MUC2 | 5.90e-06 | 1106 | 126 | 18 | M39071 |
| Coexpression | NABA_ECM_AFFILIATED | 1.17e-05 | 158 | 126 | 7 | MM17063 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | MUC16 MUC5B MUC12 OPRPN MEGF9 MUC17 SERPING1 ITIH6 MUC2 MUC3A MUC4 MUC5AC MUC6 MUC7 | 1.59e-05 | 751 | 126 | 14 | M5885 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZNF704 NRIP1 RC3H2 ZMYND8 QRICH1 WNK1 UBAP2L PRRC2C CLPTM1 CDC27 NOTCH1 | 1.65e-05 | 467 | 126 | 11 | M1347 |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 1.96e-05 | 171 | 126 | 7 | M39234 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZNF704 NRIP1 RC3H2 ZMYND8 QRICH1 WNK1 UBAP2L PRRC2C CLPTM1 CDC27 NOTCH1 | 2.29e-05 | 484 | 126 | 11 | MM999 |
| Coexpression | GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL | 4.49e-05 | 41 | 126 | 4 | M39158 | |
| Coexpression | GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP | 4.99e-05 | 198 | 126 | 7 | M3104 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH1_UP | 5.15e-05 | 199 | 126 | 7 | M5453 | |
| Coexpression | GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP | 5.32e-05 | 200 | 126 | 7 | M5800 | |
| Coexpression | GSE27786_LSK_VS_CD8_TCELL_DN | 5.32e-05 | 200 | 126 | 7 | M4750 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 5.32e-05 | 200 | 126 | 7 | M9889 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_TH2_UP | 5.32e-05 | 200 | 126 | 7 | M5534 | |
| Coexpression | BROWNE_HCMV_INFECTION_24HR_UP | 7.66e-05 | 146 | 126 | 6 | M12275 | |
| Coexpression | NABA_MATRISOME | MUC16 MUC5B MUC12 OPRPN MEGF9 MUC17 SERPING1 ITIH6 MUC2 MUC3A MUC4 MUC5AC MUC6 MUC7 OTOG | 1.25e-04 | 1026 | 126 | 15 | M5889 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 1.66e-04 | 240 | 126 | 7 | M39236 | |
| Coexpression | BILD_SRC_ONCOGENIC_SIGNATURE | 1.89e-04 | 59 | 126 | 4 | M116 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.03e-06 | 230 | 125 | 9 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | NRIP1 RC3H2 SH3RF1 ASH1L SRCAP HEG1 PRRC2C ASXL3 DEPDC5 TNS1 RAD23B | 2.88e-05 | 406 | 125 | 11 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | NRIP1 SH3RF1 ASH1L SRCAP HEG1 ZFHX4 ASXL3 DEPDC5 TBX20 STAG3 RAD23B | 3.08e-05 | 409 | 125 | 11 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | NRIP1 RC3H2 SH3RF1 ASH1L SRCAP HEG1 PRRC2C ASXL3 DEPDC5 TNS1 RAD23B | 3.36e-05 | 413 | 125 | 11 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_500 | 4.70e-05 | 67 | 125 | 5 | gudmap_developingGonad_e12.5_ovary_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 4.96e-05 | 162 | 125 | 7 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.70e-05 | 225 | 125 | 8 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NRIP1 RC3H2 DCAF6 SH3RF1 CDK12 ASH1L TSC1 SRCAP HEG1 MEGF9 PRRC2C ASXL3 DEPDC5 TNS1 RAD23B | 6.41e-05 | 790 | 125 | 15 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | NRIP1 RC3H2 SH3RF1 ASH1L TSC1 SRCAP HEG1 ZFHX4 UBAP2L PRRC2C ASXL3 DEPDC5 TBX20 STAG3 RAD23B | 7.80e-05 | 804 | 125 | 15 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_200 | 8.63e-05 | 76 | 125 | 5 | gudmap_developingGonad_e16.5_epididymis_200_k4 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.55e-04 | 136 | 125 | 6 | gudmap_kidney_adult_RenalCapsule_k4_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | HIVEP2 CD248 MUC16 CCDC80 CNKSR2 PLEKHA6 ADGRG6 HEG1 PTPRC SERPING1 OSMR TNS1 PLCE1 NPAS2 | 1.99e-04 | 778 | 125 | 14 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#1_top-relative-expression-ranked_500 | 2.14e-04 | 50 | 125 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.49e-04 | 210 | 125 | 7 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | NRIP1 RC3H2 SH3RF1 ASH1L TSC1 SRCAP HEG1 ZFHX4 UBAP2L PRRC2C ASXL3 DEPDC5 TBX20 RAD23B | 3.19e-04 | 815 | 125 | 14 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 3.29e-04 | 101 | 125 | 5 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | ZNF704 NPAS3 HIPK2 MED13L WNK1 CREB5 PCDH17 ZFHX4 KMT2A NOTCH1 | 2.82e-10 | 199 | 126 | 10 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 2.74e-09 | 183 | 126 | 9 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 2.87e-09 | 184 | 126 | 9 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.33e-08 | 187 | 126 | 8 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.33e-08 | 187 | 126 | 8 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.84e-08 | 198 | 126 | 8 | 1fe60443c11d34b6d2671af8f06e0dedc8d1558b | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.41e-07 | 164 | 126 | 7 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.32e-07 | 173 | 126 | 7 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.95e-07 | 179 | 126 | 7 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.25e-07 | 180 | 126 | 7 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.25e-07 | 180 | 126 | 7 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.89e-07 | 182 | 126 | 7 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.22e-07 | 183 | 126 | 7 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-07 | 184 | 126 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-07 | 184 | 126 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-07 | 184 | 126 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-07 | 184 | 126 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 9.91e-07 | 185 | 126 | 7 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-06 | 186 | 126 | 7 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-06 | 186 | 126 | 7 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.14e-06 | 189 | 126 | 7 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-06 | 195 | 126 | 7 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.67e-06 | 200 | 126 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.39e-06 | 135 | 126 | 6 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.15e-06 | 167 | 126 | 6 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.15e-06 | 167 | 126 | 6 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.72e-06 | 169 | 126 | 6 | 7c994653b0d629dfb046755d6b678452de0a15d2 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-06 | 173 | 126 | 6 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-06 | 173 | 126 | 6 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-06 | 173 | 126 | 6 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 175 | 126 | 6 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 179 | 126 | 6 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-05 | 180 | 126 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-05 | 180 | 126 | 6 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-05 | 181 | 126 | 6 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 184 | 126 | 6 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 184 | 126 | 6 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.41e-05 | 184 | 126 | 6 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 186 | 126 | 6 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.60e-05 | 188 | 126 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 188 | 126 | 6 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 1.65e-05 | 189 | 126 | 6 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.65e-05 | 189 | 126 | 6 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.70e-05 | 190 | 126 | 6 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-05 | 190 | 126 | 6 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 190 | 126 | 6 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-05 | 190 | 126 | 6 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-05 | 191 | 126 | 6 | 79b399496bd7322a1d53c43378f48695fd09a5d9 | |
| ToppCell | facs-Trachea-24m-Endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-05 | 191 | 126 | 6 | 9c6d5d045781c6506ae80e318427ef1e0d87f45c | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-05 | 191 | 126 | 6 | 1b1e943709d0c3283a980c7c965ef1f110506a29 | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 1.80e-05 | 192 | 126 | 6 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 192 | 126 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 193 | 126 | 6 | c0f0052c24b7fe9e21d2bc6c38047a8e755f87b6 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-05 | 193 | 126 | 6 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.85e-05 | 193 | 126 | 6 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-05 | 193 | 126 | 6 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 193 | 126 | 6 | 682ce63b73a7d02eef240673db67058d7507f744 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.96e-05 | 195 | 126 | 6 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | COPD-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 2.02e-05 | 196 | 126 | 6 | af96fb94886e9395f3e2cd0a293af29229d017fe | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.14e-05 | 198 | 126 | 6 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.14e-05 | 198 | 126 | 6 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-20|World / Primary Cells by Cluster | 2.14e-05 | 198 | 126 | 6 | bce0bc1e3f2257e0f42a1fa6e5b57cf71e4514ba | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.14e-05 | 198 | 126 | 6 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.20e-05 | 199 | 126 | 6 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | 84e145619a500530f42ed0fe72468ae95f4cbf1e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.26e-05 | 200 | 126 | 6 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | distal-Endothelial-Vein-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.26e-05 | 200 | 126 | 6 | ff88d28162e0231d5dac0e0c6bec98fa8da58a23 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.12e-05 | 135 | 126 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 8.19e-05 | 156 | 126 | 5 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.50e-05 | 161 | 126 | 5 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 163 | 126 | 5 | 73c03e29a6d7a6863c5e9aa5e8b963ef691f1ddb | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-04 | 164 | 126 | 5 | 9eed945e9b0c1ee5fc62724ac2bbbed4267b0678 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-04 | 164 | 126 | 5 | f510f20e37e31b486cdd0e3f597ce4ff00877c5d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 164 | 126 | 5 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-04 | 164 | 126 | 5 | 5c932a462cbf81d029c8d11ec3aea3191529527b | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.04e-04 | 164 | 126 | 5 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.10e-04 | 166 | 126 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 167 | 126 | 5 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 167 | 126 | 5 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 168 | 126 | 5 | 2fb2d916eb5000a637240d38e47a9b4f61f9f83f | |
| ToppCell | Posterior_cortex-Endothelial-MURAL|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.19e-04 | 169 | 126 | 5 | 0ae65daf092396b71f790b65c7a2feed90397417 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.19e-04 | 169 | 126 | 5 | 8cd70ce27b1cecb83f8a376230e7ef41b079b124 | |
| ToppCell | Club_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.19e-04 | 169 | 126 | 5 | 03b303af8a26c6ff196507fe24f5bd3d75d7b1af | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 170 | 126 | 5 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 170 | 126 | 5 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-04 | 171 | 126 | 5 | b51bbeacb172e8b5de519ada85543d7ae9914b3c | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.30e-04 | 172 | 126 | 5 | 9a256db817c1af1802203cc88a55d608fb328c63 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 173 | 126 | 5 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 173 | 126 | 5 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 173 | 126 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 174 | 126 | 5 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.37e-04 | 174 | 126 | 5 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 1.37e-04 | 174 | 126 | 5 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-04 | 175 | 126 | 5 | 019ea30ac55748463d7917abf3d3f0e804189bfd | |
| Drug | Sulindac [38194-50-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | PRR36 ZMYND8 ASH1L USP24 SREBF1 ADGRL1 CIC MICALL1 LARP4B KMT2A MCF2L SZRD1 RAD23B | 6.71e-11 | 197 | 125 | 13 | 1693_DN |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | NRIP1 HIVEP2 SETD1B NACA ZMYND8 NSD1 HIPK2 ARHGEF11 ADGRG6 LRP8 | 3.91e-08 | 172 | 125 | 10 | 7073_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | NRIP1 SETD1B ATN1 ZMYND8 HIPK2 QRICH1 MICALL1 OSMR MED12 NPAS2 | 4.13e-08 | 173 | 125 | 10 | 4237_DN |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | NRIP1 HIVEP2 SETD1B ZMYND8 NSD1 QRICH1 MED13L LRP8 NPAS2 RAD23B | 4.36e-08 | 174 | 125 | 10 | 7105_DN |
| Drug | cellobiitol | 4.91e-08 | 37 | 125 | 6 | CID000003871 | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | ATN1 ZMYND8 ADGRL1 PHF8 RGP1 UBAP2L RIPOR1 OSMR NOTCH1 SZRD1 | 1.16e-07 | 193 | 125 | 10 | 7232_DN |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.21e-07 | 194 | 125 | 10 | 3969_DN | |
| Drug | rioprostil | 8.23e-07 | 32 | 125 | 5 | CID005311413 | |
| Drug | trichostatin A; Down 200; 0.1uM; PC3; HG-U133A | 9.46e-07 | 187 | 125 | 9 | 448_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A | ATN1 ZMYND8 POM121L2 CNKSR2 SRCAP KANSL3 DEPDC5 MCF2L RAD23B | 1.23e-06 | 193 | 125 | 9 | 3811_UP |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.34e-06 | 195 | 125 | 9 | 2805_UP | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; HL60; HG-U133A | 1.34e-06 | 195 | 125 | 9 | 1366_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.46e-06 | 197 | 125 | 9 | 2260_DN | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A | 1.46e-06 | 197 | 125 | 9 | 7197_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.46e-06 | 197 | 125 | 9 | 3433_DN | |
| Drug | sulfasalazine; Up 200; 100uM; MCF7; HG-U133A | 1.46e-06 | 197 | 125 | 9 | 204_UP | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A | 1.52e-06 | 198 | 125 | 9 | 4800_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.52e-06 | 198 | 125 | 9 | 6287_DN | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; HL60; HG-U133A | 1.65e-06 | 200 | 125 | 9 | 2018_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.68e-06 | 175 | 125 | 8 | 7236_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 5.68e-06 | 175 | 125 | 8 | 5908_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 6.44e-06 | 178 | 125 | 8 | 3998_DN | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; PC3; HT_HG-U133A | 7.58e-06 | 182 | 125 | 8 | 6331_UP | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 7.89e-06 | 183 | 125 | 8 | 1709_DN | |
| Drug | Gastrin tetrapeptide | 8.00e-06 | 50 | 125 | 5 | CID000005415 | |
| Drug | mucic acid | 9.10e-06 | 88 | 125 | 6 | CID000000607 | |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.08e-05 | 191 | 125 | 8 | 4981_DN | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.08e-05 | 191 | 125 | 8 | 5351_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.08e-05 | 191 | 125 | 8 | 3392_UP | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A | 1.21e-05 | 194 | 125 | 8 | 4524_DN | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.25e-05 | 195 | 125 | 8 | 4345_DN | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.25e-05 | 195 | 125 | 8 | 6330_UP | |
| Drug | 5162773; Down 200; 7uM; MCF7; HT_HG-U133A_EA | 1.30e-05 | 196 | 125 | 8 | 892_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; HL60; HG-U133A | 1.30e-05 | 196 | 125 | 8 | 2031_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 1.40e-05 | 198 | 125 | 8 | 4301_UP | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; HL60; HT_HG-U133A | 1.40e-05 | 198 | 125 | 8 | 1869_DN | |
| Drug | Bisoprolol fumarate; Down 200; 9uM; MCF7; HT_HG-U133A | 1.45e-05 | 199 | 125 | 8 | 2642_DN | |
| Drug | Glutethimide, para-amino [125-84-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.51e-05 | 200 | 125 | 8 | 7463_UP | |
| Drug | fullerene C60 | DCAF6 ASH1L AKNAD1 SREBF1 POU2F1 MUC5B PLEKHG2 PPP1R15A SRCAP ARHGEF11 PCDH17 KANSL3 KLF7 BAZ2A CLPTM1 RIPOR1 MCF2L MUC4 TNS1 SH3RF3 MUC6 MUC7 | 2.07e-05 | 1498 | 125 | 22 | ctd:C069837 |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 4.52e-05 | 171 | 125 | 7 | 7535_DN | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 4.69e-05 | 172 | 125 | 7 | 910_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.86e-05 | 173 | 125 | 7 | 4665_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.83e-05 | 178 | 125 | 7 | 7245_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.83e-05 | 178 | 125 | 7 | 992_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.25e-05 | 180 | 125 | 7 | 3688_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 6.47e-05 | 181 | 125 | 7 | 7077_DN | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 6.70e-05 | 182 | 125 | 7 | 848_UP | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 6.94e-05 | 183 | 125 | 7 | 7498_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 7.18e-05 | 184 | 125 | 7 | 7555_DN | |
| Drug | guanidine hydrochloride | 7.96e-05 | 129 | 125 | 6 | CID000005742 | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 8.22e-05 | 188 | 125 | 7 | 4845_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; PC3; HT_HG-U133A | 8.49e-05 | 189 | 125 | 7 | 4308_UP | |
| Drug | Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 8.78e-05 | 190 | 125 | 7 | 4421_DN | |
| Drug | Rimexolone [49697-38-3]; Up 200; 10.8uM; HL60; HT_HG-U133A | 9.07e-05 | 191 | 125 | 7 | 2955_UP | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.07e-05 | 191 | 125 | 7 | 3855_DN | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 9.07e-05 | 191 | 125 | 7 | 3975_DN | |
| Drug | troglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 9.37e-05 | 192 | 125 | 7 | 1173_DN | |
| Drug | inulin | 9.42e-05 | 133 | 125 | 6 | CID000024763 | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 9.68e-05 | 193 | 125 | 7 | 6400_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A | 9.68e-05 | 193 | 125 | 7 | 4285_DN | |
| Drug | 15d-PGJ2; Up 200; 10uM; MCF7; HG-U133A | 9.68e-05 | 193 | 125 | 7 | 201_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 1.00e-04 | 194 | 125 | 7 | 1060_UP | |
| Drug | ICI 182,780; Up 200; 1uM; PC3; HT_HG-U133A | 1.00e-04 | 194 | 125 | 7 | 1205_UP | |
| Drug | Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.00e-04 | 194 | 125 | 7 | 3680_UP | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.00e-04 | 194 | 125 | 7 | 3285_UP | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.00e-04 | 194 | 125 | 7 | 4387_DN | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.00e-04 | 194 | 125 | 7 | 4529_DN | |
| Drug | Xylazine [7361-61-7]; Down 200; 18.2uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 4147_DN | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 1501_DN | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 2087_UP | |
| Drug | Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 3254_DN | |
| Drug | Atovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 4201_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 4369_DN | |
| Drug | Calycanthine [595-05-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 5744_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 2264_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 3333_DN | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 4252_UP | |
| Drug | Edrophonium chloride [116-38-1]; Down 200; 19.8uM; PC3; HG-U133A | 1.07e-04 | 196 | 125 | 7 | 1936_DN | |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 5488_UP | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 4844_DN | |
| Drug | PNU-0251126 [267429-19-6]; Up 200; 1uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 3692_UP | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 4769_DN | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 7010_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 3623_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 4108_DN | |
| Drug | Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; HL60; HG-U133A | 1.10e-04 | 197 | 125 | 7 | 1564_UP | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 5483_UP | |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 4135_DN | |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; PC3; HG-U133A | 1.10e-04 | 197 | 125 | 7 | 1909_UP | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; HL60; HG-U133A | 1.10e-04 | 197 | 125 | 7 | 1392_DN | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 3247_UP | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 2766_UP | |
| Drug | Azacyclonol [115-46-8]; Down 200; 15uM; HL60; HG-U133A | 1.14e-04 | 198 | 125 | 7 | 2020_DN | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; HL60; HG-U133A | 1.14e-04 | 198 | 125 | 7 | 1609_DN | |
| Drug | 5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA | 1.14e-04 | 198 | 125 | 7 | 889_DN | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; PC3; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 6347_UP | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 6681_DN | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 3305_DN | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 3738_DN | |
| Drug | Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 6345_UP | |
| Disease | cholangiocarcinoma (is_marker_for) | 3.63e-10 | 64 | 128 | 8 | DOID:4947 (is_marker_for) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.68e-09 | 5 | 128 | 4 | DOID:3030 (is_marker_for) | |
| Disease | mean platelet volume | HIVEP2 SETD1B CDK12 NACA ZMYND8 CRTC1 SRCAP PTPRC BAZ2A EFCAB8 SERPING1 RIPOR1 MAML2 CAMTA1 MCF2L ABCG8 PLCE1 | 2.11e-06 | 1020 | 128 | 17 | EFO_0004584 |
| Disease | Prostatic Neoplasms | DCAF6 CDK12 ASH1L PTPRC BAZ2A TIRAP ITSN2 KMT2A CDC27 MUC4 MED12 RAD23B | 1.62e-05 | 616 | 128 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | DCAF6 CDK12 ASH1L PTPRC BAZ2A TIRAP ITSN2 KMT2A CDC27 MUC4 MED12 RAD23B | 1.62e-05 | 616 | 128 | 12 | C0376358 |
| Disease | cystitis (is_marker_for) | 1.87e-05 | 2 | 128 | 2 | DOID:1679 (is_marker_for) | |
| Disease | cortical thickness | FNIP2 SREBF1 DAB1 STOX1 PCDH17 LRP8 MICALL1 MEGF9 CCAR1 KMT2A OSMR CAMTA1 TNS1 SH3RF3 PLCE1 RAD23B | 2.68e-05 | 1113 | 128 | 16 | EFO_0004840 |
| Disease | Neurodevelopmental Disorders | 5.44e-05 | 93 | 128 | 5 | C1535926 | |
| Disease | Lujan Fryns syndrome | 5.59e-05 | 3 | 128 | 2 | C0796022 | |
| Disease | sputum mucin-5B amount | 5.59e-05 | 3 | 128 | 2 | OBA_2050332 | |
| Disease | keratoconjunctivitis (is_marker_for) | 5.59e-05 | 3 | 128 | 2 | DOID:9368 (is_marker_for) | |
| Disease | neuroimaging measurement | DAB1 CNKSR2 ARHGEF11 RGP1 POM121C LRP8 CSRNP2 PRRC2C HEY2 CAMTA1 TNS1 SH3RF3 SZRD1 PLCE1 RAD23B | 6.38e-05 | 1069 | 128 | 15 | EFO_0004346 |
| Disease | alcohol consumption measurement, waist-hip ratio | 1.11e-04 | 4 | 128 | 2 | EFO_0004343, EFO_0007878 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.46e-04 | 61 | 128 | 4 | DOID:3587 (is_marker_for) | |
| Disease | Intellectual Disability | 1.51e-04 | 447 | 128 | 9 | C3714756 | |
| Disease | Weaver syndrome | 1.85e-04 | 5 | 128 | 2 | C0265210 | |
| Disease | mucositis (biomarker_via_orthology) | 1.85e-04 | 5 | 128 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | Epithelioid hemangioendothelioma | 1.85e-04 | 5 | 128 | 2 | C0206732 | |
| Disease | cerebellum cortex volume change measurement, age at assessment | 1.93e-04 | 26 | 128 | 3 | EFO_0008007, EFO_0021497 | |
| Disease | unipolar depression, depressive symptom measurement | 1.93e-04 | 26 | 128 | 3 | EFO_0003761, EFO_0007006 | |
| Disease | cortical surface area measurement | FNIP2 SREBF1 DAB1 NPAS3 HIPK2 STOX1 MED13L RGP1 LRP8 PRRC2C CCAR1 HEY2 TNS1 SH3RF3 PLCE1 RAD23B | 2.42e-04 | 1345 | 128 | 16 | EFO_0010736 |
| Disease | QRS duration | 3.33e-04 | 298 | 128 | 7 | EFO_0005055 | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 3.87e-04 | 7 | 128 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | red blood cell density measurement | ZNF704 CDK12 CRTC1 R3HDM2 ARHGEF11 WNK1 LARP4B PTPRC KLF7 MAML2 CAMTA1 MUC4 | 4.61e-04 | 880 | 128 | 12 | EFO_0007978 |
| Disease | platelet component distribution width | NRIP1 HIVEP2 ZMYND8 WNK1 MICALL1 PTPRC KLF7 BAZ2A PRRC2C CAMTA1 NPAS2 | 4.63e-04 | 755 | 128 | 11 | EFO_0007984 |
| Disease | Schizophrenia | NRIP1 SREBF1 NPAS3 PLEKHA6 ARHGEF11 PCDH17 LRP8 MED15 KMT2A MAGEC1 MED12 NPAS2 | 4.75e-04 | 883 | 128 | 12 | C0036341 |
| Disease | common bile duct neoplasm (is_marker_for) | 5.14e-04 | 8 | 128 | 2 | DOID:4608 (is_marker_for) | |
| Disease | Attached earlobe | 5.14e-04 | 8 | 128 | 2 | HP_0009907 | |
| Disease | hemangiopericytoma (is_marker_for) | 6.59e-04 | 9 | 128 | 2 | DOID:264 (is_marker_for) | |
| Disease | influenza A severity measurement | 6.59e-04 | 9 | 128 | 2 | EFO_0007743 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 6.59e-04 | 9 | 128 | 2 | EFO_0009824 | |
| Disease | insomnia measurement | 7.22e-04 | 443 | 128 | 8 | EFO_0007876 | |
| Disease | thiamine measurement | 8.21e-04 | 10 | 128 | 2 | EFO_0010540 | |
| Disease | dry eye syndrome (is_marker_for) | 8.21e-04 | 10 | 128 | 2 | DOID:10140 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 8.21e-04 | 10 | 128 | 2 | DOID:10754 (is_marker_for) | |
| Disease | allergic conjunctivitis (is_marker_for) | 8.21e-04 | 10 | 128 | 2 | DOID:11204 (is_marker_for) | |
| Disease | Inhalant adrenergic use measurement | 8.25e-04 | 96 | 128 | 4 | EFO_0009941 | |
| Disease | heart rate response to exercise | 8.67e-04 | 43 | 128 | 3 | EFO_0009184 | |
| Disease | FEV/FEC ratio | HIVEP2 DEPTOR NSD1 CRTC1 R3HDM2 CNKSR2 TFE3 ADGRG6 MED15 SERPING1 RIPOR1 MAML2 TNS1 RAD23B | 9.12e-04 | 1228 | 128 | 14 | EFO_0004713 |
| Disease | pancreatic cancer (is_marker_for) | 9.97e-04 | 101 | 128 | 4 | DOID:1793 (is_marker_for) | |
| Disease | pulmonary fibrosis | 1.00e-03 | 11 | 128 | 2 | EFO_0009448 | |
| Disease | outer ear morphology trait | 1.20e-03 | 12 | 128 | 2 | EFO_0007664 | |
| Disease | alcohol dependence | 1.24e-03 | 183 | 128 | 5 | MONDO_0007079 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.27e-03 | 49 | 128 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | hematocrit | NRIP1 HIVEP2 ASH1L SREBF1 CRTC1 R3HDM2 PLEKHA6 ADGRG6 KLF7 MAML2 OSMR CDC27 | 1.53e-03 | 1011 | 128 | 12 | EFO_0004348 |
| Disease | gastric ulcer (implicated_via_orthology) | 1.64e-03 | 14 | 128 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | lobe size | 1.64e-03 | 14 | 128 | 2 | EFO_0007666 | |
| Disease | serum urea measurement | 1.64e-03 | 195 | 128 | 5 | EFO_0009795 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.89e-03 | 15 | 128 | 2 | C0496930 | |
| Disease | caffeine measurement | 1.89e-03 | 15 | 128 | 2 | EFO_0021177 | |
| Disease | Benign neoplasm of bladder | 1.89e-03 | 15 | 128 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.89e-03 | 15 | 128 | 2 | C0154091 | |
| Disease | retinal vasculature measurement | 1.92e-03 | 517 | 128 | 8 | EFO_0010554 | |
| Disease | idiopathic pulmonary fibrosis | 1.97e-03 | 57 | 128 | 3 | EFO_0000768 | |
| Disease | body surface area | 2.01e-03 | 643 | 128 | 9 | EFO_0022196 | |
| Disease | eosinophil count | NRIP1 HIVEP2 ZMYND8 SREBF1 STOX1 WNK1 KANSL3 SPATC1 LARP4B PTPRC RASAL3 KLF7 MUC2 MUC5AC NOTCH1 | 2.03e-03 | 1488 | 128 | 15 | EFO_0004842 |
| Disease | coronary artery disease | HIVEP2 CDK12 SREBF1 DAB1 R3HDM2 CNKSR2 QRICH1 MAP1S MCF2L TBX20 TNS1 ABCG8 PLCE1 | 2.09e-03 | 1194 | 128 | 13 | EFO_0001645 |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 2.15e-03 | 16 | 128 | 2 | EFO_0008297 | |
| Disease | ureidopropionic acid measurement | 2.15e-03 | 16 | 128 | 2 | EFO_0010542 | |
| Disease | mood instability measurement | 2.38e-03 | 128 | 128 | 4 | EFO_0008475 | |
| Disease | plasma beta-amyloid 1-40 measurement | 2.43e-03 | 17 | 128 | 2 | EFO_0005659 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 2.43e-03 | 17 | 128 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 2.43e-03 | 17 | 128 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 2.43e-03 | 17 | 128 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 2.43e-03 | 17 | 128 | 2 | C0751780 | |
| Disease | otitis media (biomarker_via_orthology) | 2.43e-03 | 17 | 128 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | May-White Syndrome | 2.43e-03 | 17 | 128 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 2.43e-03 | 17 | 128 | 2 | C0751781 | |
| Disease | cystic fibrosis (is_marker_for) | 2.50e-03 | 62 | 128 | 3 | DOID:1485 (is_marker_for) | |
| Disease | obesity (implicated_via_orthology) | 2.51e-03 | 215 | 128 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | NRIP1 POU2F1 WNK1 CIC MICALL1 PTPRC ITSN2 HEY2 CDC27 TNS1 MED12 NOTCH1 | 2.52e-03 | 1074 | 128 | 12 | C0006142 |
| Disease | Carcinoma of bladder | 2.73e-03 | 18 | 128 | 2 | C0699885 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 2.73e-03 | 18 | 128 | 2 | C0751779 | |
| Disease | Brugada syndrome | 3.04e-03 | 19 | 128 | 2 | MONDO_0015263 | |
| Disease | cumulative dose response to bevacizumab | 3.04e-03 | 19 | 128 | 2 | EFO_0005944 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 3.04e-03 | 19 | 128 | 2 | EFO_0000220, GO_0097327 | |
| Disease | interstitial lung disease | 3.12e-03 | 67 | 128 | 3 | EFO_0004244 | |
| Disease | neutrophil percentage of granulocytes | 3.23e-03 | 228 | 128 | 5 | EFO_0007994 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 3.23e-03 | 228 | 128 | 5 | EFO_0003948, MONDO_0004975 | |
| Disease | body weight | HIVEP2 SH3RF1 POM121L2 CRTC1 CNKSR2 RGP1 POM121C ADGRG6 KLF7 ASXL3 EFCAB8 HEY2 ITIH6 | 3.34e-03 | 1261 | 128 | 13 | EFO_0004338 |
| Disease | skin pigmentation | 3.39e-03 | 69 | 128 | 3 | EFO_0003784 | |
| Disease | Nonorganic psychosis | 3.39e-03 | 69 | 128 | 3 | C0349204 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.44e-03 | 447 | 128 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 3.71e-03 | 21 | 128 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 4.07e-03 | 22 | 128 | 2 | EFO_0009312 | |
| Disease | hemoglobin measurement, mean corpuscular hemoglobin | 4.07e-03 | 22 | 128 | 2 | EFO_0004509, EFO_0004527 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 4.08e-03 | 346 | 128 | 6 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | diabetic nephropathy | 4.20e-03 | 150 | 128 | 4 | EFO_0000401 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TVSVNPLTRSPPETS | 561 | Q9NR48 | |
| PAFSQVPASSTSTLP | 571 | Q9NYV4 | |
| NEPLTPSSNTSLSPV | 1461 | Q9Y6Y1 | |
| VALPTSLSLSTPQPT | 111 | Q8IX12 | |
| LNPPTTASFTPTSIL | 41 | Q9H175 | |
| TLCQATVNSPSTTPP | 376 | Q86SQ4 | |
| ATSPPLSTTTTARPT | 406 | O94910 | |
| SPAVSPTTSPAVSLV | 426 | Q9UIF9 | |
| PTAQPSLTTTSRSPV | 586 | Q9HCU0 | |
| FPPVPTVTTSSATLS | 601 | P54259 | |
| TSSLSTRSLENPTPP | 656 | O15085 | |
| SSVTPLDTNCLPSPT | 376 | Q9H221 | |
| STPEAIPALSETTPT | 1446 | O60306 | |
| SQSDISTLPTVPSSP | 376 | Q58WW2 | |
| LPLPSETSPISNSSI | 746 | Q9C0F0 | |
| TTLPPAPATTVTRST | 351 | Q76M96 | |
| LSASTEPAVPTPTQT | 1446 | Q9HC84 | |
| LLPSSPTSAPITTVV | 2296 | Q9HC84 | |
| PPVLTTTATTPAATS | 2716 | Q9HC84 | |
| STLLPSSPTSAPITT | 2851 | Q9HC84 | |
| PPVLTTTATTPAATS | 3416 | Q9HC84 | |
| STLLPSSPTSAPITT | 3551 | Q9HC84 | |
| LPSSPTSAPITTVVT | 4111 | Q9HC84 | |
| PTQSPAPSPVTSLSS | 766 | Q9Y2K5 | |
| PLVSSTLPVATQSPT | 791 | Q9HBD1 | |
| PSRTSQTQPTATSPL | 6 | Q86YV0 | |
| SSTTTTVAQAPTPVP | 101 | P54727 | |
| ALAPTSTPASITPAS | 116 | P54727 | |
| VTSPSSSPSVRSQPL | 2336 | Q96L73 | |
| SPLLQEVPSASSSPT | 1026 | O14917 | |
| ALPPPTENSSLSSIT | 956 | Q99650 | |
| SPTQTPPTTSTIRVA | 16 | O95755 | |
| SAAPSIQTPSLQSPS | 146 | Q2TAL8 | |
| LPPAAPITSLSSATS | 131 | Q9NZM3 | |
| LPPSLNLTTPASTSQ | 641 | Q99743 | |
| PSPQSSSVITQAPST | 136 | Q02930 | |
| SVSTSPDPILTLSAP | 716 | O75140 | |
| TAISPPLSVSATSSP | 301 | Q9UBP5 | |
| TTLASTSVPTPVFPT | 886 | Q8WXI7 | |
| LPTLSTYPESTNTPS | 1236 | Q8WXI7 | |
| STSIPLTSSPTTPDV | 1746 | Q8WXI7 | |
| DTPAIPLTATEPTSS | 2646 | Q8WXI7 | |
| SSTSPQSIPSSPLPV | 5351 | Q8WXI7 | |
| SPPNLSSPTQERLTT | 5686 | Q8WXI7 | |
| LSSQAPLLVTTSPSP | 6221 | Q8WXI7 | |
| PLLVTTSPSPVTSTL | 6226 | Q8WXI7 | |
| TTPSPMTSLLTPSLV | 6826 | Q8WXI7 | |
| ISSTLPVTISSSPLP | 7111 | Q8WXI7 | |
| SSPLPVTSLLTSSPV | 7121 | Q8WXI7 | |
| VSSTLPESISSSPLP | 7986 | Q8WXI7 | |
| ASSLLSLPATTSPSP | 8266 | Q8WXI7 | |
| SLPATTSPSPVSSTL | 8271 | Q8WXI7 | |
| SPPSSLVSLSAVTSP | 8851 | Q8WXI7 | |
| PVSSTLLDSSPSSPL | 9741 | Q8WXI7 | |
| SLPVTTSPSVSSTLP | 10026 | Q8WXI7 | |
| TSPSVSSTLPQSIPS | 10031 | Q8WXI7 | |
| SDTLSTALSPSSLPP | 431 | Q99102 | |
| DTTPLPVTIPSSASS | 4141 | Q99102 | |
| QNSSSRPPSSPITTQ | 2096 | Q6W4X9 | |
| LPISTVTVSPTPSSH | 2226 | Q6W4X9 | |
| TSLPSSLVPPVTAAQ | 2466 | P46531 | |
| QPATTTVSTSLPVPN | 61 | Q9H2X6 | |
| ETPPTSVSESLPTLS | 781 | Q66K74 | |
| SPASTPSTTRPLNSV | 1081 | Q71F56 | |
| SPLQIPVSPSSSSTL | 231 | O60732 | |
| TSLSLPQSFPESPQS | 751 | O60732 | |
| SPESPLQSPVISFSS | 846 | O60732 | |
| ASTNATVPITTTPFP | 1891 | Q2M2H8 | |
| ATVPITTTPSPTNTA | 2056 | Q2M2H8 | |
| TPLSTPPNVSSSLPN | 286 | Q86T24 | |
| PPPATTSTTPVLSSQ | 431 | Q68D85 | |
| TSTTPVLSSQPPTLL | 436 | Q68D85 | |
| PLSPVTSVSNLLTPS | 1186 | Q5HYC2 | |
| PISQTTSQTSSIPPL | 31 | Q92615 | |
| TSQTSSIPPLSQVPA | 36 | Q92615 | |
| TSTAPIAELTTSNPP | 4201 | Q02817 | |
| LSTETSLPPTSSSLP | 361 | Q02505 | |
| SSTATSLPPTSPLVS | 736 | Q02505 | |
| SARPTSVIPSSPTVQ | 1606 | Q02505 | |
| SETAVTPTPVTPSSL | 2466 | Q02505 | |
| FPPTTAVSAIPSSSI | 401 | Q96RN5 | |
| ALVSSPSLSPSLSPA | 771 | Q9UQ05 | |
| PAPVSSFSRTSITPS | 61 | Q5T0T0 | |
| TSQAPTRPAPTTLST | 136 | Q9H1U4 | |
| NRTTPVSTPPLLTSS | 546 | P48552 | |
| SAQSTSTLPTTPAPQ | 321 | Q93074 | |
| PSATPSPALSVESLS | 501 | Q8N3F8 | |
| NAVTSLTPPSSPELS | 131 | O75840 | |
| PTTFSFSTPPLVVSS | 1326 | P98088 | |
| SHEPTISPLTPVSVS | 306 | O14520 | |
| TTLPQSSSTPVLPRA | 736 | Q9ULI3 | |
| PSITLTSQPATPTRT | 241 | P14859 | |
| TSQPATPTRTIAATP | 246 | P14859 | |
| SLPTTTSTTAPTFQP | 736 | A8CG34 | |
| TTTPATAPTTTAPLF | 771 | A8CG34 | |
| PPALPTTTTVTTFSQ | 471 | A6NF01 | |
| LPSPVANSTSTPLTL | 541 | Q86XN7 | |
| ANSTSTPLTLPVQSP | 546 | Q86XN7 | |
| FSVSNTPSVTPALPS | 791 | Q86XN7 | |
| SALSTSSPIPSVPQS | 396 | Q8IZL2 | |
| APITTPNSSPTTLAP | 306 | Q8TAX7 | |
| TSQPLSPLISSSSPS | 1646 | Q9Y2F5 | |
| NLTPVTSTTPSTNSP | 501 | O75553 | |
| SPTLSPLSPITQAVA | 326 | Q6UUV9 | |
| SSLLITPFPSPSSST | 246 | Q9P278 | |
| SSSPTLSSSPPVLCN | 291 | Q8TB45 | |
| TTPTSSVSPPQEARL | 421 | Q2V2M9 | |
| TSAPSLPVSSPVTLD | 486 | Q5T1N1 | |
| TTQLPTDSPTQPTTG | 106 | P05155 | |
| EQSQSLPLPAPTSTS | 961 | O15068 | |
| PLPESLSTFPNTISS | 896 | Q6UXX5 | |
| AASSPTPSITLSQVP | 26 | A8MWE9 | |
| PVPSVVSSSTAPSAL | 711 | Q9P2N6 | |
| ELSPLTPPSSVSSSL | 766 | Q03164 | |
| SPPETPVLTRSSAQT | 756 | Q9ULU4 | |
| SLTALPSSTYTPPNS | 206 | Q92622 | |
| SSGPQTSTTPQVLSP | 351 | P30260 | |
| TSTTPQVLSPTITSP | 356 | P30260 | |
| LTPTHVTLTTPSQPS | 896 | P80192 | |
| SSVSVPRAPSISPST | 786 | Q14114 | |
| TQTLPSSSVPSSPVQ | 631 | O75807 | |
| SSSVPSSPVQTTPLS | 636 | O75807 | |
| TPESSSLPVALQTPT | 1576 | Q6ZRI0 | |
| PLLTSIPVSTTPVAS | 1631 | Q685J3 | |
| PPLTSIPVSTTTVAS | 1926 | Q685J3 | |
| SIPLSTTPVASPEAS | 2106 | Q685J3 | |
| SPVITSTEVSSSPIP | 2131 | Q685J3 | |
| LLTSIPVSTTPVASP | 2516 | Q685J3 | |
| PVSTTPVASPEASTL | 2521 | Q685J3 | |
| PVASPEASTLSTTPV | 2526 | Q685J3 | |
| TPVAIPEASTLSTTP | 3056 | Q685J3 | |
| SNPTSTPTVPRTTTC | 4121 | Q685J3 | |
| TTTPPSTLVTTLPTA | 311 | Q9H195 | |
| STEATSPPTTPLTVF | 706 | Q9H195 | |
| PSPPTARTSQTSVAT | 826 | Q9H195 | |
| VVSSPNSTSRPTLPV | 71 | Q7Z422 | |
| TVDPISSSLTSAPAP | 181 | Q8N983 | |
| SPIRPVSSPVLSSSN | 1166 | Q9P212 | |
| VTNPLPPTATSASSE | 26 | Q92546 | |
| TQASLISPSRPASTP | 636 | Q9H6K5 | |
| SVPASTSAPLPATLT | 1761 | Q9Y520 | |
| SPISSSSSQLSPLAP | 531 | Q9UPS6 | |
| TPEPVESTSPSLLTT | 241 | Q8IXF0 | |
| PISSTPEPATSISAA | 181 | Q99935 | |
| SQTPFTLSLTPPSTD | 181 | Q15562 | |
| SPLASPVSSTVSVPL | 1421 | Q6ZRS2 | |
| PVSSTVSVPLSSSLP | 1426 | Q6ZRS2 | |
| VSVPLSSSLPISVPT | 1431 | Q6ZRS2 | |
| LSLTPASSLVPTPAQ | 1716 | Q6ZRS2 | |
| STPSISNLTPAITSP | 741 | Q96KW2 | |
| ISPPVLISSSNPTAA | 326 | Q7Z6J0 | |
| SLSPPPATLSSSLEA | 71 | P36956 | |
| TVATSTTPPAATILP | 1121 | Q96RK0 | |
| LTPTPAPTTTTATRE | 621 | O96005 | |
| LIPRSPTSSVATPSS | 321 | Q8WXI2 | |
| PASPLSSASLTSPLS | 691 | Q9Y2H5 | |
| PPSLSLPSTVTSSLC | 3496 | Q86UP3 | |
| SSPSTRLITEPPQAT | 331 | Q92574 | |
| PPSTQETSSSLLPQS | 311 | Q9Y397 | |
| STVSAPPPVVSVSSS | 741 | Q14157 | |
| SSLPISLQATPATPA | 76 | P19532 | |
| TTAQSSVCTLPPPFT | 581 | A0A1B0GUW6 | |
| SLQLNSIPPTPTLTS | 1096 | Q9UJ98 | |
| STPTPSSIQVPARTS | 621 | O94991 | |
| PTTSPTVTVLASAPA | 326 | Q76KD6 | |
| PTATVSPLRTQNSPS | 621 | Q8TEJ3 | |
| SSQPLTSNSLLPLTP | 971 | Q6ZVD7 | |
| VSPSPLSTSSPILSA | 1071 | Q9HBL0 | |
| LTVSSPPVASLSPTS | 1826 | Q86WI1 | |
| SSLAPVSPSQSLASP | 251 | Q6ZNC4 | |
| TSQDSPLPPSLSSVT | 51 | P58753 | |
| LSLSAPSSPEISPQS | 2066 | Q9UPU5 | |
| PTVAATPQLVTSSSP | 956 | Q9UPP1 | |
| SVPNTPSLSSTPTLS | 676 | Q9H7P9 | |
| SSSSLCTEPLIPTTP | 76 | Q9UMR3 | |
| PPVSESPVLSSVVSS | 1401 | Q9H4A3 | |
| VPTSSATNLTIPPSL | 546 | P31629 | |
| PTTSPILINVSPSTS | 671 | Q6ZS17 | |
| STFPTDPVSPLTTTL | 156 | P08575 | |
| TSITTPTLSPSQQPL | 71 | Q9H8U3 | |
| PVATATTPSPARSTT | 1891 | Q9UKN1 | |
| ISSPPSTTSALVEEP | 1951 | Q9UKN1 | |
| PVATATTPSPARSTT | 4531 | Q9UKN1 | |
| PQTTPTTTLAIASPQ | 231 | E9PAV3 |